Both in Biotechnology
Adaptive Biotechnologies vs Relay Therapeutics
Over the past year ADPT returned +113.7% and RLAY returned +253.8%; their daily moves had a correlation of 0.25.
ADPT +113.7% RLAY +253.8%Growth of $1, one year, split-adjusted
| Metric | ADPT | RLAY |
|---|---|---|
| Price | $28.77 | $18.36 |
| Market cap | $4.59B | $4.02B |
| Today | +0.91% | +3.79% |
| 1 month | +14.2% | −2.2% |
| 6 months | +123.9% | +96.4% |
| Year to date | +77.2% | +117.0% |
| 1 year | +117.6% | +255.1% |
| Revenue growth (YoY) | +21.5% | −48.3% |
| Gross margin | 71.8% | 100.0% |
| Net margin | −55.6% | −23916.3% |
| P/E (TTM) | — | — |
| Price / sales | 14.9× | 388.7× |
| Net cash | $9.4M | $910.9M |
| Dividend yield | — | — |
| Volatility (60d) | 50.2% | 44.5% |
| Short % of float | 11.2% | 28.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).